home / stock / halb / halb news


HALB News and Press, Tykhe Corp From 08/31/20

Stock Information

Company Name: Tykhe Corp
Stock Symbol: HALB
Market: OTC
Website: halberdcorporation.com

Menu

HALB HALB Quote HALB Short HALB News HALB Articles HALB Message Board
Get HALB Alerts

News, Short Squeeze, Breakout and More Instantly...

HALB - Halberd Selects Arizona State University (ASU) to Develop Its Patented COVID-19 Treatment(s)

JACKSON CENTER, PA / ACCESSWIRE / August 31, 2020 / Halberd Corporation (OTC PINK: HALB ) today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd's Covid-19 treatments. The work will focus on developing antib...

HALB - Halberd Corporation Selects University Research Partner

JACKSON CENTER, PA / ACCESSWIRE / August 27, 2020 / Halberd Corp. (OTC PINK: HALB ) is pleased to announce the successful completion of its search for a major research university partner. The University, to be announced, is engaged to develop compounds for use in Halberd's patented extracorp...

HALB - Halberd Corporation CEO Answers Shareholders' Questions Regarding Covid-19 Treatment

JACKSON CENTER, PA / ACCESSWIRE / August 18, 2020 / Halberd Corp. (OTC PINK: HALB ) Chairman, President & CEO of Halberd Corporation, William A. Hartman, has received a number of questions from shareholders regarding the extracorporeal process for treatment of Covid-19. Below, Mr. Hartma...

HALB - Halberd Corporation Adds Edson Brito to Scientific Advisory Board

JACKSON CENTER, PA / ACCESSWIRE / August 12, 2020 / Halberd Corp. (OTC PINK: HALB ) today announced the addition of Edson Brito to the Scientific Advisory Board. Mr. Brito is CEO and Chief Business Development Officer of Cellybri Advanced Therapies in Brazil. Mr. Brito graduated with a Ch...

HALB - Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board Furthering the Fight Against Covid-19 Internationally

JACKSON CENTER, PA / ACCESSWIRE / August 10, 2020 / Halberd Corp. (OTC PINK: HALB ) today confirmed the addition of Dr. Abdon Nanhay as a member of the Scientific Advisory Board. Dr. Nanhay, a Brazilian physician, has over 25 years of experience in health and biological sciences Dr. Nan...

HALB - Halberd Corporation Adds Dr. Gregory George as Member of Scientific Advisory Board

JACKSON CENTER, PA / ACCESSWIRE / August 6, 2020 / Halberd Corp. (OTC PINK: HALB ) today confirmed the signing of Dr. Gregory George as a member of the Scientific Advisory Board. Dr. George is a Family Medicine Specialist in Sharon, PA and is affiliated with the Sharon Regional Health Syst...

HALB - Halberd Corporation Secures $2 Million for Covid-19 Research

JACKSON CENTER, PA / ACCESSWIRE / August 4, 2020 / Halberd Corp. (OTC PINK: HALB ) announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s). Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, I...

HALB - Retired NFL Great Carl Eller Joins Halberd Corporation

Will Assist with Covid-19 Efforts and the Brain JACKSON CENTER, PA / ACCESSWIRE / July 27, 2020 / Halberd Corp. (OTC PINK: HALB ) announced the appointment of Carl Eller, retired NFL Pro Football Hall of Famer, and President of the NFL Retired Players Association as a consultant. Mr. El...

HALB - Halberd Corporation CTO, Dr. Patricio Reyes, Presents Information at Virtual Event on Covid-19's Effects on Neurological Functions

JACKSON CENTER, PA / ACCESSWIRE / July 22, 2020 / Halberd Corporation (OTC PINK: HALB ) announced their Chief Technical Officer and Head of Scientific Advisory Board, Dr. Patricio Reyes presented A Community Information Session virtual event hosted yesterday by the Brain Injury Alliance ...

HALB - Halberd Advances the Treatment of COVID-19 Utilizing Laser Technology

JACKSON CENTER, PA / ACCESSWIRE / July 16, 2020 / Halberd Corp. (OTC PINK: HALB ) intends to use laser technology to eradicate the COVID-19 Coronavirus. This patent pending treatment introduces one or more fluorescent antibody-antigen complexing agents to bind with the target antigen(s) (i.e...

Previous 10 Next 10